Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes.

作者: Mitchell A Hamman , Barbara D Haehner-Daniels , Steven A Wrighton , Allan E Rettie , Stephen D Hall

DOI: 10.1016/S0006-2952(00)00301-4

关键词:

摘要: The stereoselective sulfoxidation of the pharmacologically active metabolite sulindac, sulindac sulfide, was characterized in human liver, kidney, and cDNA-expressed enzymes. Kinetic parameter estimates (pH = 7.4) for sulfoxide formation liver microsomes (N 4) R- S-sulindac were Vmax 1.5 ± 0.50 nmol/min/mg, Km 15 5.1 μM; 1.1 0.36 16 6.1 μM, respectively. Kidney 3) produced 0.9 0.29 2.9 0.5 0.21 22 1.9 μM sulfoxide, In flavin-containing monooxygenase 3 (FMO3) R-sulindac increased 60–70% at pH 8.5, but unchanged. fourteen microsomal preparations, significant correlations occurred between either immunoquantified FMO or nicotine N-oxidation (r 0.88 0.83; P < 0.01). rate also correlated significantly 0.85 0.75; 0.01) with thirteen kidney samples. Mild heat deactivation reduced activity by 30–60%, a loss stereoselectivity observed. Methimazole potent nonstereoselective inhibitor microsomes. n-Octylamine membrane solubilization lubrol selective inhibitors formation. CYPs failed to appreciably sulfoxidate CYP ineffective suppressing catalytic activity. Purified mini-pig FMO1, rabbit lung FMO2, FMO3 efficiently oxidized sulfide high degree towards R-isomer, FMO5 lacked biotransformation is catalyzed predominately FMOs may prove be useful characterizing

参考文章(30)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
J Catlow, B J Ring, S A Wrighton, S P Swanson, T J Lindsay, M A Hamman, T Gillespie, B J Cerimele, L K Roskos, Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. Journal of Pharmacology and Experimental Therapeutics. ,vol. 276, pp. 658- 666 ,(1996)
C G Arman, E A Risley, D E Duggan, K F Hooke, T Y Shen, Identification of the biologically active form of sulindac. Journal of Pharmacology and Experimental Therapeutics. ,vol. 201, pp. 8- 13 ,(1977)
Ian R. Phillips, Colin T. Dolphin, Philippe Clair, Mark R. Hadley, Andrew J. Hutt, Richard R. McCombie, Robert L. Smith, Elizabeth A. Shephard, The molecular biology of the flavin-containing monooxygenases of man. Chemico-Biological Interactions. ,vol. 96, pp. 17- 32 ,(1995) , 10.1016/0009-2797(94)03580-2
M.W. Anders, J. Harris Ratnayake, Patrick E. Hanna, James A. Fuchs, Involvement of thioredoxin in sulfoxide reduction by mammalian tissues. Biochemical and Biophysical Research Communications. ,vol. 97, pp. 846- 851 ,(1980) , 10.1016/0006-291X(80)91454-0
David M. Clive, Jeffrey S. Stoff, Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs New England Journal of Medicine. ,vol. 310, pp. 563- 572 ,(1984) , 10.1056/NEJM198403013100905
A.E. Rettie, M.P. Lawton, A.J.M. Sadeque, G.P. Meier, R.M. Philpot, Prochiral Sulfoxidation as a Probe for Multiple Forms of the Microsomal Flavin-Containing Monooxygenase: Studies with Rabbit FMO1, FMO2, FMO3, and FMO5 Expressed in Escherichia coli Archives of Biochemistry and Biophysics. ,vol. 311, pp. 369- 377 ,(1994) , 10.1006/ABBI.1994.1250
Paul A. Abraham, William F. Keane, Glomerular and Interstitial Disease Induced by Nonsteroidal Anti-Inflammatory Drugs American Journal of Nephrology. ,vol. 4, pp. 1- 6 ,(1984) , 10.1159/000166764